6533b822fe1ef96bd127cb04

RESEARCH PRODUCT

Extent and duration of angiotensin ii antagonistic activity of irbesartan and candesartan cilexetil

R. ButzerT. RoenzS. KoberC. HausdorfC. MangP. LangguthG. G. BelzE. Mutschler

subject

Clinical pharmacologybusiness.industryPharmacologyAngiotensin IIlaw.inventionCandesartanIrbesartanLosartanValsartanlawRenin–angiotensin systemInternal Medicinemedicinebusinessmedicine.drughttps://doi.org/10.1016/s0895-7061(00)00638-5